Innovators, investors and entrepreneurs are encouraged to save the date Feb. 6
as the Moffitt Cancer Center will host its annual Business of Biotech conference.
The conference offers businesses and investors the opportunity to network with each other in an effort to bring biotech concepts to fruition. In fact, that is the theme of this year’s conference, “Turning Vision into Reality.”
“Our team wanted to develop a conference theme that reflects today’s biotech progress in the Tampa Bay area,” says Jarett Rieger, director of technology management and commercialization at Moffitt Cancer Center
. “Speakers at the conference will look at the history of biotechnology, the current state and the future of diagnostics, medical devices and personalized medicine.”
The keynote speaker for the event is Dr. Risa Stack, a venture capitalist with Kleiner, Perkins, Caufield & Byers
. She has experience investing in personalized medicine, therapeutics and platform technologies.
“Dr. Stack has over 15 years of experience in investing and she will share her knowledge with the audience, focusing on personalized medicine,” Rieger says. “Other speakers will give talks on fundraising, personalized medicine, the future of biotech and issues facing medical device companies.”
According to Rieger, last year’s conference attracted more than 310 attendees, including scientists, investors, entrepreneurs, businesses and students. He expects attendance to surpass 300 again this year.
“The Business of Biotech conference is an opportunity to network with other members within the Tampa Bay biotech cluster to learn about what’s new in the region, ask questions of local area experts and gain a national perspective on biotechnology.”
The one-day conference will be held at Moffitt’s Vincent A. Stabile Research Building
. Those interested in attending should register online
or email Patricia Teston
Writer: Kimberly Patterson
Source: Jarett Rieger, Moffitt Cancer Center